Scientists' Mobility

I would like to comment on the two recent articles by Susan L-J Dickinson that appeared in The Scientist: one on the confrontation between Temple University and Carlo Croce's group [June 24, 1991, page 1], and one on nomadic scientists [July 22, 1991, page 1]. One aspect of American science that has made American scientists so successful is their mobility. This mobility has been generated by the system of grants, which makes the scientist essentially independent of university funds. Serious p

Written byRenato Baserga
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

I would like to comment on the two recent articles by Susan L-J Dickinson that appeared in The Scientist: one on the confrontation between Temple University and Carlo Croce's group [June 24, 1991, page 1], and one on nomadic scientists [July 22, 1991, page 1]. One aspect of American science that has made American scientists so successful is their mobility. This mobility has been generated by the system of grants, which makes the scientist essentially independent of university funds.

Serious problems can, and do, arise when scientists move from one institution to another. According to present legislation, grants are given to an institution, and not to an investigator. This, in my opinion, is a figment of the imagination: Investigator-initiated grants, for all practical purposes, are given to the investigator.

The transfer of a grant to a new institution should be automatic, with the granting agency intervening only to ensure that ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies